Log In
Print
BCIQ
Print
Print this Print this
 

Glymera (PB1023)

  Manage Alerts
Collapse Summary General Information
Company PhaseBio Pharmaceuticals Inc.
DescriptionRecombinant glucagon-like peptide-1 (GLP-1) analog
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today